Clinical controls and model calibration as keys to complete blood count-based studies of pediatric fistula-in-ano.

This commentary appraises a single-center evaluation of complete blood count (CBC) markers for pediatric fistula-in-ano. We commend the pragmatic focus of this study on low-cost tests and the dual assessment of discrimination and clinical utility. To strengthen robustness and generalizability, two priorities are emphasized: First, the use of clinical controls, children with perianal symptoms but without pediatric fistula-in-ano, to avoid spectrum bias; and second rigorous calibration and validation (k-fold or temporal splits, bootstrap optimism correction, calibration intercept/slope, and Brier score), with decision curve analyses derived from validated predictions. Given rapid hematologic maturation, age should be modeled nonlinearly and CBC values should be expressed as age-specific z-scores/percentiles. Additional refinements include clear timing/indication of blood draws, appropriate correlations (Spearman or age-adjusted partials), and odds ratios per interquartile range with multicollinearity checks (variance inflation factor). These steps can translate promising CBC signals into reliable, clinically actionable evidence.